These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27504633)

  • 1. The Promise of Mineralocorticoid Antagonism in Acute Kidney Injury.
    Chandrashekar KB; Lopez-Ruiz A; Juncos LA
    Nephron; 2016; 134(3):154-159. PubMed ID: 27504633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid Receptor Antagonism: A Promising Therapeutic Approach to Treat Ischemic AKI.
    Barrera-Chimal J; Bobadilla NA; Jaisser F
    Nephron; 2016; 134(1):10-3. PubMed ID: 26991656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1.
    Barrera-Chimal J; André-Grégoire G; Nguyen Dinh Cat A; Lechner SM; Cau J; Prince S; Kolkhof P; Loirand G; Sauzeau V; Hauet T; Jaisser F
    J Am Soc Nephrol; 2017 Apr; 28(4):1216-1226. PubMed ID: 28087726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia.
    Barrera-Chimal J; Prince S; Fadel F; El Moghrabi S; Warnock DG; Kolkhof P; Jaisser F
    J Am Soc Nephrol; 2016 Feb; 27(2):398-404. PubMed ID: 26361797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of cardiovascular risk in chronic kidney disease by mineralocorticoid receptor antagonism.
    Epstein M
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):993-1003. PubMed ID: 26429402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardioprotective effects of mineralocorticoid receptor antagonists.
    van den Berg TN; Rongen GA; Fröhlich GM; Deinum J; Hausenloy DJ; Riksen NP
    Pharmacol Ther; 2014 Apr; 142(1):72-87. PubMed ID: 24275323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid Receptor Antagonism in AKI: A New Hope?
    Juncos LA; Juncos LI
    J Am Soc Nephrol; 2016 Feb; 27(2):335-7. PubMed ID: 26361798
    [No Abstract]   [Full Text] [Related]  

  • 8. Kidney-Heart Interactions in Acute Kidney Injury.
    Doi K
    Nephron; 2016; 134(3):141-144. PubMed ID: 27304926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal antagonists of the mineralocorticoid receptor.
    Kolkhof P; Nowack C; Eitner F
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):417-24. PubMed ID: 26083526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: a focus on the cardiomyocyte.
    Bienvenu LA; Reichelt ME; Delbridge LM; Young MJ
    Clin Sci (Lond); 2013 Nov; 125(9):409-21. PubMed ID: 23829554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria: a therapeutic target in acute kidney injury.
    Ishimoto Y; Inagi R
    Nephrol Dial Transplant; 2016 Jul; 31(7):1062-9. PubMed ID: 26333547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor and cardiac arrhythmia.
    Gravez B; Tarjus A; Jaisser F
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):910-5. PubMed ID: 23888997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone blockade in chronic kidney disease.
    Hirsch JS; Drexler Y; Bomback AS
    Semin Nephrol; 2014 May; 34(3):307-22. PubMed ID: 25016401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mineralocorticoid receptor: an update].
    Nagase M
    Nihon Rinsho; 2012 Sep; 70(9):1504-9. PubMed ID: 23012795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretics in acute kidney injury.
    Nigwekar SU; Waikar SS
    Semin Nephrol; 2011 Nov; 31(6):523-34. PubMed ID: 22099509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from ischemic acute kidney injury by spironolactone administration.
    Sánchez-Pozos K; Barrera-Chimal J; Garzón-Muvdi J; Pérez-Villalva R; Rodríguez-Romo R; Cruz C; Gamba G; Bobadilla NA
    Nephrol Dial Transplant; 2012 Aug; 27(8):3160-9. PubMed ID: 22516623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the Mechanisms of the Acute Kidney Injury-to-Chronic Kidney Disease Continuum.
    Takaori K; Yanagita M
    Nephron; 2016; 134(3):172-176. PubMed ID: 27398799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid receptor antagonists for heart failure.
    Richards AM
    Expert Opin Pharmacother; 2011 Dec; 12(18):2801-15. PubMed ID: 22082128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the mineralocorticoid receptor in cardiovascular disease.
    Young MJ
    Expert Opin Ther Targets; 2013 Mar; 17(3):321-31. PubMed ID: 23324064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?
    Gomez-Sanchez EP
    J Cardiovasc Pharmacol; 2016 Jan; 67(1):26-38. PubMed ID: 26466326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.